Home
About
Services
Our people
Contact
News
Home
About
Services
Our people
Contact
News
Tag
Phase I
September 17, 2018
Product Development and Clinical Investigation of a MERS-CoV Vaccine based on highly efficient scalable recombinant MVA technology
CEPI awarded a program which is aimed at the manufacturing and stockpiling of clinical supplies of MVA-MERS-S and the concomitant clinical development to a stage where outbreak deployment readiness is...
Read More
CR2O
Press Releases
,
Project Updates
Tag Cloud
19
Amsterdam UMC
Biotech NEWS
CEPI
COVID-19
ENDFLU
ErasmusMC
EU
GLORIA
Glucocorticoids
Hannover
Harbour
Horizon2020
IDT
Immunology
India
Influenza
Interview
ISOLDA
Magazine
MANCO
MERS
Phase I
Phase II
Rheumatoid Arthritis
SARS-CoV-2
TiHo
Vaccines
WBVR
Winter 2020
Search
Downloads